Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |